Clinical Trials Directory

Trials / Completed

CompletedNCT01607970

Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making

Double-blind, Placebo-controlled, Randomized Study: Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University Hospital, Bonn · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether oxytocin affects the modulation of startle reactivity by aversive social stimuli and to investigate the oxytocin effect on moral judgements. Furthermore the investigators explore the effects of oxytocin receptor (OXTR) polymorphisms on behavioral responses to social stimuli.

Detailed description

The neuropeptide oxytocin (OXT) can enhance the impact of positive social cues but may reduce that of negative ones, although it is unclear whether the latter causes blunted emotional responses. After OXT or placebo application participants are exposed to acoustic startle probes presented alone and during viewing of 60 color pictures mostly selected from the 'International Affective Picture System'. The paradigm featured 20 negative (mostly threatening), 20 neutral, and 20 positive pictures, presented for 5 s each. In the other part of the experiment, after intranasal OXT or placebo application participants respond to 60 moral dilemmas.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinOxytocin: 24 IU; 3 puffs per nostril, each with 4 IU OXT

Timeline

Start date
2011-08-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-05-30
Last updated
2012-05-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01607970. Inclusion in this directory is not an endorsement.